Suggestions
Joe Fitchett
Senior Adviser at Institut Pasteur de Dakar
Dr. Joe Fitchett is the Senior Adviser for Biotechnology at the Institut Pasteur de Dakar in Senegal.1 In this role, he is responsible for the IPD vaccine pipeline and oversees the strategy to launch new capabilities for developing and producing regionally-relevant countermeasures for epidemics.1 He is involved in several key projects, including:
- Project sponsor for the technology transfer of the first measles/rubella vaccine to be produced in Africa1
- Overseeing the IPD-CEPI partnering agreement for outbreak vaccines1
- Helping establish the Advanced Vaccine Bioprocessing lab and the Grand Challenges Sénégal innovation fund1
Prior to his current position, Dr. Fitchett's experience includes:
- Medical Director at Global Access Dx (formerly Mologic) from October 2018 to September 20211
- Frank Knox Fellow at Harvard University from 2015 to 20211
- Program Officer for Global Policy & Advocacy at the Bill & Melinda Gates Foundation from 2016 to 20181
Dr. Fitchett has a background in public health and infectious disease epidemiology from Harvard, clinical medicine from Imperial and Kings, and immunology of infectious diseases from the London School of Hygiene & Tropical Medicine (LSHTM).1 He has been involved in various research projects, including the establishment of the TB Centre at LSHTM and work on the HIV self-testing Africa (STAR) initiative.1
Highlights
Institut Pasteur de Dakar is recruiting an Innovation Manager, responsible for advancing the Grand Challenges project in Senegal and managing the innovation fund.
Please consider putting yourself forward by January 10th, 2023!
The Institut Pasteur de Dakar is hosting and curating the newly launched Grand Challenges Senegal initiative. The Innovation Manager will also be the point of contact at the Institut Pasteur de Dakar for the organizing committee of the Grand Challenges Annual Meeting, which will be hosted in Dakar in October 2023.
Grand Challenges initiatives are united by their focus on fostering innovation, directing research to where it will have the most impact, and serving those most in need. Grand Challenges Senegal will be no different and prioritize innovators that a) integrate across disciplines and converge solutions, b) prioritize Senegal as a setting to exemplify the work but with regional impact and potential for reach, and c) apply the very latest science into an ecosystem that is evolving into a hub for translational impact and production.
Senegal is rapidly advancing with its strategy to manufacture countermeasures for epidemics, starting with vaccines and diagnostics, and the ecosystem the country builds post-COVID represents an unparalleled opportunity to simultaneously enhance its research and development (R&D) environment. The Innovation Manager will work closely with the senior leadership at Institut Pasteur de Dakar and the Director of Partnerships to engage existing and new donors to contribute to the fund.
The first call for proposals for Grand Challenges Senegal is supported by Grand Challenges Canada and the Bill & Melinda Gates Foundation and will focus on “Interventions to enhance epidemic intelligence, surveillance and outbreak response”.
Karine Belondrade || Amadou Lamine FALL || Kedest Tesfagiorgis || Mohamed Ndiaye || Jenniffer Mabuka-Maroa PhD || Karlee Silver || Deepika Devadas
